Comparison of extended intervals and dose reduction of omalizumab for asthma control
Crossref DOI link: https://doi.org/10.1007/s15007-019-1783-3
Published Online: 2019-01-29
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bölke, Georg
Church, Martin K.
Bergmann, Karl-Christian
Text and Data Mining valid from 2019-01-29
Article History
Received: 22 October 2018
Accepted: 15 November 2018
First Online: 29 January 2019